Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
Accenture
McKinsey
UBS
Farmers Insurance

Generated: May 22, 2019

DrugPatentWatch Database Preview

Details for Patent: 6,740,341

« Back to Dashboard

Which drugs does patent 6,740,341 protect, and when does it expire?

Patent 6,740,341 protects ORAPRED ODT and is included in one NDA.

This patent has nine patent family members in seven countries.

Summary for Patent: 6,740,341
Title: Taste masking rapid release coating system
Abstract:The present invention relates to a core containing a drug encased in a spacing layer and a taste masking layer which provides effective taste masking for in-mouth disintegrable dosage forms containing highly objectionable tasting drugs, as well as dosage forms containing these cores.
Inventor(s): Holt; Kris E. (Maple Grove, MN), Khankari; Rajendra K. (Maple Grove, MN), Hontz; John (Plymouth, MN)
Assignee: Cima Labs Inc. (Eden Prairie, MN)
Application Number:09/449,851
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,740,341
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 6,740,341
Patent Claim Types:
see list of patent claims
Use; Formulation; Composition; Dosage form;

Drugs Protected by US Patent 6,740,341

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Concordia Pharms Inc ORAPRED ODT prednisolone sodium phosphate TABLET, ORALLY DISINTEGRATING;ORAL 021959-001 Jun 1, 2006 AB RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Concordia Pharms Inc ORAPRED ODT prednisolone sodium phosphate TABLET, ORALLY DISINTEGRATING;ORAL 021959-002 Jun 1, 2006 AB RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Concordia Pharms Inc ORAPRED ODT prednisolone sodium phosphate TABLET, ORALLY DISINTEGRATING;ORAL 021959-003 Jun 1, 2006 AB RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Merck
Chinese Patent Office
UBS
QuintilesIMS
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.